Roger Marshall: “I call up my amendment No. 5389 and ask that it be reported by number. The PRESIDING OFFICER. The clerk will report. The…”

“I call up my amendment No. 5389 and ask that it be reported by number. The PRESIDING OFFICER. The clerk will report. The legislative clerk read as follows: The Senator from Kansas [Mr. Marshall] proposes an amendment numbered 5389 to amendment No. 5194. The amendment is as follows: (Purpose: To protect patient access to current and future treatments for a range of serious conditions, such as cancer, Alzheimer's disease, HIV/AIDS, Parkinson's disease, and sickle cell disease, among numerous others) At the end of title I, add the following: Subtitle E--Ensuring Patient Access to Drugs and Biological Products That Treat Serious Conditions SEC. 14001. ENSURING PATIENT ACCESS TO DRUGS AND BIOLOGICAL PRODUCTS THAT TREAT SERIOUS CONDITIONS. Section 1192(e)(3) of the Social Security Act, as added by section 11001, is amended by adding at the end the following new subparagraphs: ``(D) Six protected classes.--A covered part D drug in a category or class that is identified under section 1860D- 4(b)(3)(G)(iv). ``(E) Breakthrough therapies.--A drug or biological product designated under section 506(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 356(a)) as a breakthrough therapy and approved under section 505 of such Act (21 U.S.C. 355) or section 351 of the Public Health Service Act (42 U.S.C. 262).''. SEC. 14002. REDUCTION OF ADDITIONAL IRS FUNDING FOR ENFORCEMENT AND OPERATIONS.…”